TGA closes investigation into promotion of Dr Thomas Borody’s COVID-19 treatment
The high-profile gastroenterologist has urged GPs to prescribe his ivermectin-based regimen
The TGA has closed its inquiry into the promotion of an ivermectin-based regimen as a potential treatment for COVID-19.
Last year Dr Thomas Borody, the inventor of triple therapy for H. pylori and a pioneer of faecal transplant therapy, had called on GPs to consider prescribing a triple therapy of ivermectin, doxycycline and zinc.
“The government could end the pandemic by openly encouraging GPs to prescribe these TGA-approved medications,” he claimed at the time.
As medical director of the Centre of Digestive Diseases (CDD) in Sydney, he invited GPs to email him for details of his triple therapy protocols so they could prescribe it off-label to patients in aged care, to treat or prevent COVID-19.
